This review highlights the emerging role of endothelial dysfunction markers in acute ischemic stroke, including their correlation with parenchymal hematoma after endovascular thrombectomy.
The role of endothelial dysfunction in acute ischemic stroke has been studied increasingly in recent years. It has been shown that there is a correlation between endothelial dysfunction and parenchymal hematoma after endovascular thrombectomy. Also, early clinical trials are conducted investigating, e.g., endothelial progenitor cells in the treatment of endothelial dysfunction in ischemic stroke. Current research focuses on the integration of novel markers of endothelial dysfunction into routine clinical practice to support decision making in the treatment of acute ischemic stroke.
Kleeberg et al. (Wed,) studied this question.